Ceftriaxone & Tazobactam for Injection – Zonium -TZ 562.50 Injection

Ceftriaxone & Tazobactam for Injection – Broad-Spectrum Defense with Enhanced Beta-Lactamase Protection.

Zonium -TZ 562.50 Injection: Ceftriaxone 500mg + Tazobactam 62.50mg is a combination of Ceftriaxone, a third-generation cephalosporin, with Tazobactam, a beta-lactamase inhibitor. Ceftriaxone inhibits bacterial cell wall synthesis, while Tazobactam protects it from enzymatic degradation, allowing for reliable treatment of a variety of infections. The combination is beneficial in mixed and resistant infections.

Recommended BY Specialists:
General Physicians: It is preferred to use a combination to treat the disease associated with moderate bacterial infections
Pulmonologists: It is preferred to treat the disease associated with community- or hospital-acquired pneumonia, chronic bronchitis with infection

Key Benefits of Ceftriaxone & Tazobactam for Injection – Zonium -TZ 562.50 Injection:
Broad spectrum antibiotics action: Ceftriaxone is a third-generation cephalosporin with activity against a wide range of bacterial infections, where Tazobactam is a beta-lactamase inhibition which making it highly effective against both gram-positive and gram-negative bacteria.
Reduced the risk of resistance: The combination therapy reduces the bacterial resistance, which helps to reduce the resistance of bacterial and makes it an option for treating challenging infections without contributing significantly to resistance development.
Low toxicity and better tolerability : Ceftriaxone has a favorable safety profile, and with the addition of Tazobactam, makes this combination a well-tolerated treatment option for patients with infections of varying severity.

INDICATIONS:
Respiratory Tract Infections
Urinary Tract Infections (UTIs)
Meningitis